Legal & General Group Plc Makes New Investment in Teladoc Health, Inc. $TDOC

Legal & General Group Plc purchased a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the second quarter, Holdings Channel reports. The institutional investor purchased 160,095 shares of the health services provider’s stock, valued at approximately $1,358,000.

Other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP purchased a new stake in Teladoc Health in the second quarter worth about $25,000. EverSource Wealth Advisors LLC grew its holdings in Teladoc Health by 694.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock worth $31,000 after acquiring an additional 4,945 shares in the last quarter. PNC Financial Services Group Inc. increased its position in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 2,810 shares during the period. IFP Advisors Inc raised its holdings in shares of Teladoc Health by 412.1% in the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 3,210 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new stake in shares of Teladoc Health in the 4th quarter valued at about $45,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

NYSE:TDOC opened at $6.29 on Monday. The company’s 50-day simple moving average is $7.79 and its 200-day simple moving average is $6.71. Teladoc Health, Inc. has a fifty-two week low of $4.40 and a fifty-two week high of $9.89. The stock has a market capitalization of $1.14 billion, a P/E ratio of -6.35 and a beta of 2.12.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The firm had revenue of $606.93 million during the quarter, compared to analyst estimates of $615.44 million. During the same quarter in the previous year, the business posted ($0.19) EPS. Teladoc Health’s revenue was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. On average, research analysts forecast that Teladoc Health, Inc. will post -0.89 EPS for the current year.

Analyst Ratings Changes

TDOC has been the topic of a number of recent research reports. Bank of America increased their price objective on shares of Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research note on Tuesday, July 7th. Canaccord Genuity Group reduced their price objective on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Finally, Citigroup dropped their target price on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research report on Monday, August 3rd. Five investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and a consensus price target of $7.54.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.